Literature DB >> 16038117

Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis.

J C Crispín, E Díaz-Jouanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16038117     DOI： 10.1191/0961203305lu2147xx

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  7 in total

1.  Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.

Authors:  Maxwell J Heinrich; Caroline A Purcell; Andrea J Pruijssers; Yang Zhao; Charles F Spurlock; Subramaniam Sriram; Kristen M Ogden; Terence S Dermody; Matthew B Scholz; Philip S Crooke; John Karijolich; Thomas M Aune
Journal:  J Autoimmun       Date:  2019-02-28       Impact factor: 7.094

2.  Possible involvement of interferon beta in post-operative vasculitis restricted to the tumour bed: a case report.

Authors:  Tatsuya Abe; Kenji Sugita; Masaki Morishige; Kouhei Ohnishi; Keisuke Ishii; Tohru Kamida; Takamitsu Hikawa; Minoru Fujiki; Hidenori Kobayashi; Kenji Kashima; Shigeo Yokoyama
Journal:  Neurosurg Rev       Date:  2008-07-11       Impact factor: 3.042

Review 3.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.

Authors:  Nisha Mistry; Jonathan Shapero; Richard I Crawford
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

4.  Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Authors:  Ally-Khan Somani; Alan R Swick; Kevin D Cooper; Thomas S McCormick
Journal:  Arch Dermatol       Date:  2008-10

5.  Acute renal failure, systemic lupus erythematosus and thrombotic microangiopathy following treatment with beta-interferon for multiple sclerosis: case report and review of the literature.

Authors:  Thomas Hansen; David New; Roy Reeve; Rosemary Donne; William Stephens
Journal:  NDT Plus       Date:  2009-09-22

6.  Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.

Authors:  Julien Mahe; Aurélie Meurette; Anne Moreau; Caroline Vercel; Pascale Jolliet
Journal:  Drug Des Devel Ther       Date:  2013-08-07       Impact factor: 4.162

7.  A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.

Authors:  Zisis Tsouris; Christos Liaskos; Efthymios Dardiotis; Thomas Scheper; Vana Tsimourtou; Wolfgang Meyer; George Hadjigeorgiou; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2020-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.